ovary

Postoperative chemotherapy in advanced ovarian granulosa cell tumors
I. A Al-Badawi, P. M. A Brasher, P Ghatage, J. G Nation, A Schepansky, G. C. E Stuart

International Journal of Gynecologic Cancer Jan 2002, 12 (1) 119-123; DOI: 10.1136/ijgc-00009577-200201000-00019
Immunohistochemical localization of metallothionein in benign and malignant epithelial ovarian tumors
W. G Mccluggage, K Strand, A Abdulkadir

International Journal of Gynecologic Cancer Jan 2002, 12 (1) 62-65; DOI: 10.1136/ijgc-00009577-200201000-00010
Carcinosarcoma of ovary associated with previous radiotherapy
L.-H. Wei, C.-Y. Huang, S.-P. Cheng, C.-A. Chen, C.-Y. Hsieh, C.-Y. Huang

International Journal of Gynecologic Cancer Jan 2001, 11 (1) 81-84; DOI: 10.1136/ijgc-00009577-200101000-00013
Risk of second malignant neoplasms following female genital tract cancers in New South Wales (Australia), 1972-91
M. R.E. McCredie, G. J. Macfarlane, M. S. Coates, R. A. Osborn

International Journal of Gynecologic Cancer Sep 1996, 6 (5) 362-368; DOI: 10.1136/ijgc-00009577-199609000-00003
Pure malignant immature teratoma of the ovary: the role of chemotherapy and second-look surgery
S. Culine, C. Lhomme, J. Kattan, G. Michel, P. Duvillard, J. P. Droz

International Journal of Gynecologic Cancer Oct 1995, 5 (6) 432-437; DOI: 10.1046/j.1525-1438.1995.05060432.x
Basement membrane patterns in borderline tumors of the ovary. An immunohistochemical study with antibodies to laminin and type IV collagen
R. Visser, J. W. Arends, F. T. Bosman

International Journal of Gynecologic Cancer Jun 1995, 5 (4) 286-290; DOI: 10.1046/j.1525-1438.1995.05040286.x
‘Moderate-risk’ ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation
P. J. HOSKINS, K. D. SWENERTON, M. MANJI, F. WONG, S. E. O'REILLY, E. J. McMURTRIE, N. LE, B. ACKER, J. LE RICHER

International Journal of Gynecologic Cancer Jul 1994, 4 (4) 272-278; DOI: 10.1046/j.1525-1438.1994.04040272.x
Carcinosarcoma of the ovary treated over a 10-year period at the Christie Hospital
J. Prendiville, D. Murphy, J. Renninson, H. Buckley, D. Crowther

International Journal of Gynecologic Cancer Apr 1994, 4 (3) 200-205; DOI: 10.1046/j.1525-1438.1994.04030200.x
DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary
J. Kaern, C. G. TropÉ, G. B. Kristensen, V. M. Abeler, E. O. Pettersen

International Journal of Gynecologic Cancer Oct 1993, 3 (6) 349-358; DOI: 10.1046/j.1525-1438.1993.03060349.x
Primary treatment failure in patients with malignant ovarian germ cell neoplasms
M. J. MESSING, D. M. GERSHENSON, M. MORRIS, T. W. BURKE, J. J. KAVANAGH, J. T. WHARTON

International Journal of Gynecologic Cancer Nov 1992, 2 (6) 295-300; DOI: 10.1046/j.1525-1438.1992.02060295.x

Main menu

ovary

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

ovary

Pages